At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
Point of views, research, studies - on the latest themes - to help you expand your knowledge and be future ready.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
You have these already downloaded
We have sent you a copy of the report to your email again.
Tata Consultancy Services is helping life sciences organizations to scale R&D transformation by strengthening AI and data foundations, modernizing operating models, and turning innovation into measurable business and patient outcomes.
NEW YORK | MUMBAI, July 2, 2026: Tata Consultancy Services (TCS) has been named a Leader in the IDC MarketScape: Worldwide Life Sciences R&D Strategic Consulting (SC) Services 2026 Vendor Assessment1.
According to the IDC MarketScape: “TCS differentiates itself in life sciences SC by developing its AI-driven transformation points of view, pilot programs, and innovative solutions (with a team of over 100 research scientists and 221 patents), complemented by a robust business value framework that spans the life sciences value chain.” It goes on to say: “Consider TCS when seeking a strategic consulting partner that is strong at technical execution strategy, has robust AI and platform capabilities, offers its proprietary frameworks and blueprints, models for de novo drug discovery, has a strong footprint in the clinical trials and pharmacovigilance space, and has expertise in analytics/BI application development, process optimization, data integration strategy, application rationalization, infrastructure optimization, IT system blueprinting, clinical efficiency and productivity improvement, and regulatory compliance services.”
“TCS enables life sciences organisations to address complex R&D challenges through deep domain expertise, technology-led innovation, and disciplined execution. Our strategic consulting integrates proprietary data modernisation frameworks, industry reference architectures, and intelligent operating models to drive business transformation. This is further accelerated by our scalable GenAI and Agentic AI solutions across drug discovery, clinical development, regulatory, and pharmacovigilance. We help clients modernise platforms, reimagine processes, strengthen governance, and accelerate innovation—while adhering to the rigour of a regulated life sciences environment,” said Sanjeev Sachdeva, Global Head, Advisory & Business Process Services, Life Sciences, TCS. “We believe this leadership recognition underscores our ability to help life sciences organizations move from strategy to sustained transformation across the full R&D value chain.”
As life sciences enterprises accelerate the shift from digital experimentation to enterprise-scale value realization, TCS is enabling clients to modernize R&D operating models, strengthen data and AI foundations, and embed intelligent, compliant, and scalable ways of working across discovery, clinical development, regulatory, safety, and evidence-generation.
By combining consulting-led transformation, scientific and regulatory understanding, AI-first engineering, proprietary accelerators, and global execution capability, TCS is helping clients close the gap between innovation ambition and enterprise value—advancing more resilient, intelligent, and patient-centered R&D ecosystems. Additionally, TCS supports life sciences organizations to drive sharper portfolio decisions, enhance operational resilience, and translate innovation investments into tangible business and patient outcomes.
“TCS' combination of proprietary platforms, frameworks, and accelerators, de novo drug discovery models, and scalable GenAI solutions across R&D underpins its positioning as a Leader in the IDC MarketScape worldwide life science R&D strategic consulting assessment,” said Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy and Technology, IDC.
About IDC MarketScape: IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each supplier’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of technology suppliers can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective suppliers.
1 IDC MarketScape: Worldwide Life Sciences R&D Strategic Consulting Services 2026 Vendor Assessment, May 2026, IDC #US53009826
TCS Named a Leader in IDC MarketScape for Asia/Pacific Professional and Managed Services for Microsoft Azure
2/4TCS Named Leader in Asia/Pacific Oracle Implementation Services
3/4Al Maryah Community Bank Launches a Digital Bank in Six Months
4/4TCS ranked No. 1 in Everest Group’s Top 50™ Store Services Providers 2026 report
Whether you are a client, partner, investor, or employee, our promise is to be with you for the long run. Let’s take the first step together.
Connect with us